Thermo Fisher Scientific Inc/ US8835561023 /
11/7/2024 9:59:56 PM | Chg. -3.80 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
555.94USD | -0.68% | 49,110 Turnover: 27.38 mill. |
-Bid Size: - | -Ask Size: - | 212.63 bill.USD | 0.25% | 35.82 |
Assets
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1,767.4000 | 2,426.5000 | 2,448.8000 | 2,577.8000 | 4,047 | ||||||
Intangible Assets | 7,071.3000 | 14,110.1000 | 12,758.3000 | 13,969 | 16,684 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | 36,312.3000 | 35,147.8000 | 38,886.5000 | 47,248 | ||||||
Inventories | 1,494.5000 | 1,859.5000 | 1,991.7000 | 2,213.3000 | 2,971 | ||||||
Accounts Receivable | 1,942.3000 | 2,473.6000 | 2,544.9000 | 3,048.5000 | 3,879 | ||||||
Cash and Cash Equivalents | 5,826 | 1,343.5000 | 452.1000 | 786.2000 | 1,335 | ||||||
Current Assets | 9,880.7000 | 6,539.8000 | 5,741.2000 | 7,021 | 9,421 | ||||||
Total Assets | 31,863.4000 | 42,852.1000 | 40,889 | 45,907.5000 | 56,669 |
Liabilities
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 691.5000 | 820.7000 | 822.2000 | 926.2000 | 1,428 | ||||||
Long-term debt | - | 12,351.6000 | 11,473.9000 | 15,372.4000 | 18,873 | ||||||
Liabilities to Banks | 987.7000 | 2,212.4000 | 1,052.8000 | 1,255.5000 | 2,135 | ||||||
Provisions | 1,609.9000 | 3,430.7000 | 2,622.6000 | 2,557.4000 | 2,766 | ||||||
Liabilities | 15,007.3000 | 22,304 | 19,538.8000 | 24,368.2000 | 31,256 | ||||||
Share Capital | 369.6000 | 408.5000 | 411.9000 | 415.1000 | 428 | ||||||
Total Equity | 16,856.1000 | 20,548.1000 | 21,350.2000 | 21,539.3000 | 25,413 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 31,863.4000 | 42,852.1000 | 40,889 | 45,907.5000 | 56,669 |
Income Statement
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 13,090.3000 | 16,889.6000 | 16,965.4000 | 18,274.1000 | 20,918 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 1,609.6000 | 2,503 | 2,336.2000 | 2,449.2000 | 2,968 | ||||||
Interest Income | - | - | - | - | -511 | ||||||
Income Before Taxes | 1,319.5000 | 2,087.2000 | 1,936.4000 | 2,023.9000 | 2,429 | ||||||
Income Taxes | 40.4000 | -191.7000 | 43.9000 | 1.4000 | -201 | ||||||
Minority Interests Profit | 0.0000 | - | - | - | - | ||||||
Net Income | 1,273.3000 | 1,894.4000 | 1,975.4000 | 2,021.8000 | 2,225 |
Per Share
Cash Flow
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 2,010.7000 | 2,619.6000 | 2,816.9000 | 3,156.3000 | 4,005 | ||||||
Cash Flow from Investing Activities | -263.3000 | -11,782.7000 | -1,087.4000 | -5,532.1000 | -7,729 | ||||||
Cash Flow from Financing | 3,310 | 4,796.1000 | -2,491.3000 | 2,860.6000 | 3,854 | ||||||
Decrease / Increase in Cash | 5,020.4000 | -4,482.5000 | -891.4000 | 334.1000 | 550 | ||||||
Employees | 50,000 | 51,000 | 52,000 | 55,000 | 70,000 |